Literature DB >> 31382299

Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants.

Sfurti Nath1, Anne Marie Reynolds2, Satyan Lakshminrusimha3, ChangXing Ma4, Mark L Hudak5, Rita M Ryan6.   

Abstract

OBJECTIVE: This study aimed to compare short-term respiratory outcomes of three steroids (dexamethasone, hydrocortisone, and methylprednisolone) to facilitate extubation by improving respiratory status in preterm infants. STUDY
DESIGN: This is a retrospective, single-center, cohort study of 98 intubated preterm infants ≤346/7 weeks' gestation, admitted to a 64-bed, level III neonatal intensive care unit at the Women & Children's Hospital of Buffalo, Buffalo, NY, between 2006 and 2012, who received a short course of low-dose steroids for lung disease after first week of life.
RESULTS: Study infants received dexamethasone (34%), hydrocortisone (44%), or methylprednisolone (22%) based on clinical team preference. By day 7 after initiation of steroids, extubation occurred in 59, 44, and 41%, respectively, in infants on dexamethasone, hydrocortisone, and methylprednisolone (p = 0.3). The mean respiratory severity score (RSS = fraction of inspired oxygen × mean airway pressure), a quantitative measure of respiratory status, decreased by 44% for all infants and by 59% in the dexamethasone group by day 7.
CONCLUSION: Steroids improved short-term respiratory outcomes in all infants (RSS and extubation); by day 7, dexamethasone treatment was associated with the greatest decrease in RSS. Additional prospective, randomized trials of short-course low-dose steroids are warranted to substantiate these findings to guide clinical decision making and in evaluating differential steroid effects on long-term neurodevelopmental outcomes. Thieme. All rights reserved.

Entities:  

Year:  2019        PMID: 31382299     DOI: 10.1055/s-0039-1694004

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  5 in total

1.  Oxygen and steroids affect the regulatory role of natriuretic peptide receptor-C on surfactant secretion by type II cells.

Authors:  Rita M Ryan; Manjeet K Paintlia; Danforth A Newton; Demetri D Spyropoulos; Matthew Kemp; Alan H Jobe; John E Baatz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 5.464

2.  Let's Talk about Dex: When do the Benefits of Dexamethasone for Prevention of Bronchopulmonary Dysplasia Outweigh the Risks?

Authors:  Thuy Nguyen; Brian K Jordan
Journal:  Newborn (Clarksville)       Date:  2022-03-31

Review 3.  Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia.

Authors:  Zeyar T Htun; Elizabeth V Schulz; Riddhi K Desai; Jaime L Marasch; Christopher C McPherson; Lucy D Mastrandrea; Alan H Jobe; Rita M Ryan
Journal:  J Perinatol       Date:  2021-05-19       Impact factor: 2.521

4.  Hydrocortisone and bronchopulmonary dysplasia: variables associated with response in premature infants.

Authors:  Christie Clauss; Stacey Thomas; Igor Khodak; Valentyna Tack; Meredith Akerman; Nazeeh Hanna; Caterina Tiozzo
Journal:  J Perinatol       Date:  2020-05-07       Impact factor: 2.521

5.  Efficacy of late postnatal dexamethasone on weaning from invasive mechanical ventilation in extreme premature infants.

Authors:  Waleed Kurtom; Augusto Schmidt; Deepak Jain; Silvia Vanbuskirk; Alini Schott; Eduardo Bancalari; Nelson Claure
Journal:  J Perinatol       Date:  2021-05-28       Impact factor: 2.521

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.